ZIONS BANCORP NA (ZION)

US9897011071 - Common Stock

60.22  +1.08 (+1.83%)

Fundamental Rating

3

ZION gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 404 industry peers in the Banks industry. ZION has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ZION is valued expensive at the moment.



3

1. Profitability

1.1 Basic Checks

ZION had positive earnings in the past year.
In the past year ZION had a positive cash flow from operations.
Each year in the past 5 years ZION has been profitable.
Each year in the past 5 years ZION had a positive operating cash flow.

1.2 Ratios

ZION has a Return On Assets (0.74%) which is comparable to the rest of the industry.
With a decent Return On Equity value of 10.13%, ZION is doing good in the industry, outperforming 68.08% of the companies in the same industry.
Industry RankSector Rank
ROA 0.74%
ROE 10.13%
ROIC N/A
ROA(3y)0.96%
ROA(5y)0.92%
ROE(3y)14.55%
ROE(5y)12.11%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 21.28%, ZION is in line with its industry, outperforming 45.39% of the companies in the same industry.
In the last couple of years the Profit Margin of ZION has declined.
The Operating Margin and Gross Margin are not available for ZION so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 21.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.7%
PM growth 5Y-7.42%
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

ZION does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZION has less shares outstanding
The number of shares outstanding for ZION has been reduced compared to 5 years ago.
ZION has a better debt/assets ratio than last year.

2.2 Solvency

ZION has a debt to FCF ratio of 12.04. This is a negative value and a sign of low solvency as ZION would need 12.04 years to pay back of all of its debts.
ZION's Debt to FCF ratio of 12.04 is on the low side compared to the rest of the industry. ZION is outperformed by 75.81% of its industry peers.
A Debt/Equity ratio of 0.54 indicates that ZION is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.54, ZION is not doing good in the industry: 75.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 12.04
Altman-Z N/A
ROIC/WACCN/A
WACC11.64%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

ZION shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.24%.
The Earnings Per Share has been growing slightly by 3.46% on average over the past years.
Looking at the last year, ZION shows a decrease in Revenue. The Revenue has decreased by -6.63% in the last year.
ZION shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.29% yearly.
EPS 1Y (TTM)-9.24%
EPS 3Y16.8%
EPS 5Y3.46%
EPS Q2Q%21.24%
Revenue 1Y (TTM)-6.63%
Revenue growth 3Y3.74%
Revenue growth 5Y2.29%
Sales Q2Q%3.53%

3.2 Future

The Earnings Per Share is expected to grow by 7.21% on average over the next years.
ZION is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.10% yearly.
EPS Next Y1.94%
EPS Next 2Y1.08%
EPS Next 3Y4.32%
EPS Next 5Y7.21%
Revenue Next Year-1.22%
Revenue Next 2Y1.06%
Revenue Next 3Y2.39%
Revenue Next 5Y4.1%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.26, the valuation of ZION can be described as correct.
71.57% of the companies in the same industry are more expensive than ZION, based on the Price/Earnings ratio.
ZION is valuated cheaply when we compare the Price/Earnings ratio to 28.96, which is the current average of the S&P500 Index.
ZION is valuated correctly with a Price/Forward Earnings ratio of 12.13.
61.10% of the companies in the same industry are more expensive than ZION, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, ZION is valued a bit cheaper.
Industry RankSector Rank
PE 12.26
Fwd PE 12.13

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ZION is valued a bit more expensive than 75.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.89
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZION does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.31
PEG (5Y)3.55
EPS Next 2Y1.08%
EPS Next 3Y4.32%

6

5. Dividend

5.1 Amount

ZION has a Yearly Dividend Yield of 2.89%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.02, ZION has a dividend in line with its industry peers.
ZION's Dividend Yield is a higher than the S&P500 average which is at 2.23.
Industry RankSector Rank
Dividend Yield 2.89%

5.2 History

On average, the dividend of ZION grows each year by 9.19%, which is quite nice.
ZION has paid a dividend for at least 10 years, which is a reliable track record.
ZION has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)9.19%
Div Incr Years11
Div Non Decr Years13

5.3 Sustainability

44.20% of the earnings are spent on dividend by ZION. This is a bit on the high side, but may be sustainable.
The dividend of ZION is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP44.2%
EPS Next 2Y1.08%
EPS Next 3Y4.32%

ZIONS BANCORP NA

NASDAQ:ZION (11/22/2024, 12:38:04 PM)

60.22

+1.08 (+1.83%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.90B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.89%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.26
Fwd PE 12.13
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)6.31
PEG (5Y)3.55
Profitability
Industry RankSector Rank
ROA 0.74%
ROE 10.13%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 21.28%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-9.24%
EPS 3Y16.8%
EPS 5Y
EPS Q2Q%
EPS Next Y1.94%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.63%
Revenue growth 3Y3.74%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y